---
title: "Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1) — Share Price, Financials & Analysis"
symbol: "SOLARAPP1"
company: "Solara Active Pharma Sciences Ltd Partly Paidup"
canonical: "https://tapetide.com/stocks/SOLARAPP1"
isin: "IN9624Z01022"
nse_symbol: "SOLARAPP1"
bse_code: "890202"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 333.67
generated_at: "2026-09-13T18:33:53.748Z"
---

# Solara Active Pharma Sciences Ltd Partly Paidup (SOLARAPP1)

Canonical page: https://tapetide.com/stocks/SOLARAPP1

## Company

- **NSE Symbol:** SOLARAPP1
- **BSE Code:** 890202
- **ISIN:** IN9624Z01022
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-05-22
- **F&O Eligible:** No

## Latest Price

- **Price:** ₹302
- **Change:** 0 (0%)
- **Open:** ₹282
- **Day High:** ₹310
- **Day Low:** ₹282
- **Previous Close:** ₹302
- **Volume:** 0

## Key Fundamentals

Observed at 2026-04-01T04:35:15.333005Z.

- **Market Cap:** ₹333.67 Cr
- **Classification:** Microcap
- **P/E (reported):** 0
- **Book Value:** ₹134.75
- **Price to Book:** 2.03
- **Dividend Yield:** 0%
- **ROE:** 0%
- **ROCE:** 0%

## Growth Rates

| Metric | 1Y |
| --- | --- |
| revenue growth | 9.71% |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 6 / 6 / 7

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 292.7 | Buy |
| EMA (10) | 291.26 | Buy |
| SMA (20) | 279.92 | Buy |
| EMA (20) | 292.2 | Buy |
| SMA (50) | 314.19 | Sell |
| EMA (50) | 313.94 | Sell |
| SMA (100) | 352.01 | Sell |
| EMA (100) | 342.59 | Sell |
| SMA (200) | 396.85 | Sell |
| EMA (200) | 365.62 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.89 | Neutral |
| MACD (12,26,9) | -5.13 | Buy |
| Stochastic (14,3,3) | 70.6 | Neutral |
| ADX (14) | 13.27 | Neutral |
| Williams %R (14) | -55.07 | Neutral |
| ATR (14) | 31.77 | High Volatility |
| ROC (12) | 4.14 | Buy |
| Stoch RSI (14) | 87.75 | Sell |
| UO (7,14,28) | 57.31 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-28 | [Intimation In Connection With The Receipt Of Rectification Order](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65c35ae2-31a3-4b42-b66e-abe0b4baab6a.pdf) |
| 2026-08-26 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=547713ae-e7fc-4052-9692-2de6f67fa0d9.pdf) |
| 2026-08-25 | [Notice Of The Ninth Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a8f60d8-795a-4308-a7d5-3a963f59f036.pdf) |
| 2026-08-25 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5ffab22-4ebf-40a7-9133-ce57c66bbeab.pdf) |
| 2026-08-25 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc58f42f-3f80-48fa-b815-429e255f8f28.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=074d6e06-188d-4a52-8d76-d2d08fd80386.pdf) |
| 2026-08-19 | [Conversion Of Partly Paid-Up Rights Equity Shares Into Fully Paid-Up Equity Shares In Relation To The Rights Issue By The Company Upon Receipt Of The Call Monies As Applicable](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5ec0d47-e005-4c92-aa59-feb30e508d8d.pdf) |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb531967-4aee-4117-a42c-db873f954684.pdf) |
| 2026-08-07 | [Update With Respect To Our Intimation Dated July 23 2026 Regarding Appointment Of CIO And SMP Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68525433-d286-4bbe-bf66-c62c835f89c3.pdf) |
| 2026-07-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26a9553e-e823-47fe-a303-ab79dbb908e8.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 Apr - Second and final call of ₹112.50 per partly paid share; payment window April 23-May 7, 2026. | [Intimation Regarding Dispatch Of The Second And Final Call Money Notice Of The Rights Equity Shares. 7 Apr - Second and final call of ₹112.50 per partly paid share; payment window April 23-May 7, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/021358df-c52a-40b5-b276-6ccff963229a.pdf) |
| 4 Mar - On Mar 4, 2026 received Rs93,71,512.50 for 71,402 rights shares; converted to Rs7 paid-up; paid-up capital Rs44.51Cr. | [Receipt Of Call Money Pursuant To The Second Reminder Notice Issued For Payment Of First Call Money On Rights Shares 4 Mar - On Mar 4, 2026 received Rs93,71,512.50 for 71,402 rights shares; converted to Rs7 paid-up; paid-up capital Rs44.51Cr.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/881cd28d-c598-4a2a-9c25-920456e05322.pdf) |
| 4 Mar - Brazilian wholly-owned subsidiary Solara Active Pharma Sciences LTDA deregistered July 30, 2025; non-operational, zero FY2025 turnover. | [Intimation Regarding The Closure Of Wholly Owned Subsidiary Of The Company In Brazil. 4 Mar - Brazilian wholly-owned subsidiary Solara Active Pharma Sciences LTDA deregistered July 30, 2025; non-operational, zero FY2025 turnover.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce8f019f-6ebf-450b-980d-8b7570b3ee65.pdf) |
| 28 Apr - US FDA closed Puducherry facility inspection with VAI classification on April 24, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 28 Apr - US FDA closed Puducherry facility inspection with VAI classification on April 24, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2c5441da-8d5e-405a-915b-b67dde427e5b.pdf) |
| 28 Apr - US FDA closed Puducherry facility inspection with VAI classification on April 24, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 28 Apr - US FDA closed Puducherry facility inspection with VAI classification on April 24, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2c5441da-8d5e-405a-915b-b67dde427e5b.pdf) |
| 26 Mar - Trading window closed from April 1, 2026 until 48 hours after results for quarter/year ended March 31, 2026. | [Closure of Trading Window 26 Mar - Trading window closed from April 1, 2026 until 48 hours after results for quarter/year ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4266767e-ac14-47f6-bcee-2baf358de984.pdf) |
| 24 Mar - Solara approves second and final call of ₹112.50 per rights share; record date April 2, 2026. | [Corporate Action- Record Date For The Purpose Of Making Second And Final Call For Rights Equity Shares 24 Mar - Solara approves second and final call of ₹112.50 per rights share; record date April 2, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/66270f0b-7e7f-4bd1-ad5a-805d4677abd8.pdf) |
| 24 Mar - Second & final call ₹112.50 per rights share; record date April 02, 2026. | [General Update - Rights Issue - Second & Final Call 24 Mar - Second & final call ₹112.50 per rights share; record date April 02, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/21058a78-54c6-4adc-9f71-693cfa1a8438.pdf) |
| 18 Mar - Received Rs.161.92 Crore tax demand for AY 2019-20; appeal to be filed (received Mar 17, 2026). | [Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015 18 Mar - Received Rs.161.92 Crore tax demand for AY 2019-20; appeal to be filed (received Mar 17, 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e0715c9f-a827-4dbe-bfc6-6294b1927e13.pdf) |
| 10 Mar - Appointed Mohanraj Sanjeevi as Whole-time Executive Director (Jan 1,2026–Dec 31,2028); Rs85,00,000 fixed, Rs15,00,000 variable. | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 10 Mar - Appointed Mohanraj Sanjeevi as Whole-time Executive Director (Jan 1,2026–Dec 31,2028); Rs85,00,000 fixed, Rs15,00,000 variable.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/680529e7-274e-43ca-a5d9-ee526241ac4b.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f72e6c77-575d-4666-9bcd-68fd3384a1f0.pdf) |
| 2025-11-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c80c36b5-5724-46ea-af3b-9b63582e165c.pdf) |
| 2025-07-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd708187-046a-445e-a17f-c806a729cbdf.pdf) |
| 2025-05-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdab947e-35c8-4ae3-aec9-7835df11c109.pdf) |
| 2025-01-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5a859f1-1315-4a91-b0dd-9dc13be940f6.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-02-06 | [Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8471c1c-a0c5-469e-accb-2c46c61d4525.pdf) |
| 2025-11-05 | [Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07404f29-b83c-4023-9443-8fc587da8249.pdf) |
| 2025-07-25 | [Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=642420f6-0d93-4c62-aa5b-94cee1b14b7a.pdf) |
| 2025-05-15 | [Audited Financial Results For The Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b81dc1d2-682c-4b4c-8469-98126acb450e.pdf) |
| 2025-01-24 | [Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63f78ede-dc89-44c8-b4a2-d7ecc8a379bf.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3179c58-96eb-4700-8713-d07a88d2d286.pdf) |
| 2025-11-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3182cfc8-2dd2-4cd9-a844-184da8356c46.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:33:53.748Z.